Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-01T09:15:22.537Z Has data issue: false hasContentIssue false
  • English
  • Français

Consent to treatment

Published online by Cambridge University Press:  02 January 2018

J. Laugharne ,
J. Arcelsus  and
A. Davies
J. Laugharne
Affiliation:
University Department of Psychiatry, Northern General Hospital, Sheffield S5 7AU
J. Arcelsus
Affiliation:
University Department of Psychiatry, Northern General Hospital, Sheffield S5 7AU
A. Davies
Affiliation:
University Department of Psychiatry, Northern General Hospital, Sheffield S5 7AU
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 169 , Issue 3 , September 1996 , pp. 382
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

References

Brabbins, C., Butler, J. & Bentall, R. (1996) Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues. British Journal of Psychiatry, 168, 540–544.Google Scholar
Department of Health (1993) Code of Practice of the Mental Health Act 1983.Google Scholar
American Psychiatric Association (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association Washington, D.C: APA.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.